ETF Holdings Breakdown of GRFS

Stock NameGrifols SA ADR
TickerGRFS(USD) NASDAQ
TYPECommon Stock
CountryUSA
ISINUS3984384087
LEI959800HSSNXWRKBK4N60

News associated with GRFS

Grifols, S.A. (NASDAQ:GRFS) Shares Purchased by Mariner LLC
Mariner LLC increased its position in shares of Grifols, S.A. (NASDAQ:GRFS – Free Report) by 382.4% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 119,472 shares of the biotechnology company’s stock after purchasing an additional 94,706 shares during the period. Mariner […] - 2025-04-29 08:22:53
Legal & General Group Plc Raises Holdings in Grifols, S.A. (NASDAQ:GRFS)
Legal & General Group Plc lifted its stake in Grifols, S.A. (NASDAQ:GRFS – Free Report) by 159.5% in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 329,953 shares of the biotechnology company’s stock after purchasing an additional 202,796 shares during the quarter. Legal & General […] - 2025-04-25 08:16:54
Bank of Montreal Can Sells 6,039 Shares of Grifols, S.A. (NASDAQ:GRFS)
Bank of Montreal Can cut its holdings in shares of Grifols, S.A. (NASDAQ:GRFS – Free Report) by 7.9% during the fourth quarter, Holdings Channel reports. The fund owned 70,856 shares of the biotechnology company’s stock after selling 6,039 shares during the quarter. Bank of Montreal Can’s holdings in Grifols were worth $527,000 as of its […] - 2025-04-22 07:52:58
Grifols, S.A. (NASDAQ:GRFS) Shares Sold by Arrowstreet Capital Limited Partnership
Arrowstreet Capital Limited Partnership cut its holdings in shares of Grifols, S.A. (NASDAQ:GRFS – Free Report) by 18.8% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 363,933 shares of the biotechnology company’s stock after selling 84,503 shares during the quarter. Arrowstreet […] - 2025-04-10 08:15:10
Grifols, S.A. (NASDAQ:GRFS) Shares Sold by Oppenheimer Asset Management Inc.
Oppenheimer Asset Management Inc. lowered its holdings in Grifols, S.A. (NASDAQ:GRFS – Free Report) by 38.5% during the fourth quarter, according to the company in its most recent filing with the SEC. The fund owned 36,083 shares of the biotechnology company’s stock after selling 22,594 shares during the quarter. Oppenheimer Asset Management Inc.’s holdings in […] - 2025-03-07 08:45:05
R Squared Ltd Makes New $28,000 Investment in Grifols, S.A. (NASDAQ:GRFS)
R Squared Ltd purchased a new position in Grifols, S.A. (NASDAQ:GRFS – Free Report) during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 3,760 shares of the biotechnology company’s stock, valued at approximately $28,000. Several other institutional investors and hedge […] - 2025-02-05 08:40:56
China Universal Asset Management Co. Ltd. Raises Stock Position in Grifols, S.A. (NASDAQ:GRFS)
China Universal Asset Management Co. Ltd. raised its stake in shares of Grifols, S.A. (NASDAQ:GRFS – Free Report) by 10.2% during the fourth quarter, Holdings Channel reports. The firm owned 25,867 shares of the biotechnology company’s stock after buying an additional 2,403 shares during the quarter. China Universal Asset Management Co. Ltd.’s holdings in Grifols […] - 2025-02-04 09:14:57

GRFS institutional holdings

The following institutional investment holdings of GRFS have been identified

Date ETF ISIN/Name Num Shares Book value
2025-05-08 IE00BYXG2H39 (iShares Nasdaq US Biotechnology UCITS ETF USD (Acc)) 58,673USD 428,313
2025-05-08 IE00BDZVHG35 (iShares Nasdaq US Biotechnology UCITS ETF USD (Dist)) 58,673USD 428,313 -0.3%
Total =117,346 USD 856,626
Book value of shares is calculated on the adjusted close price of each day (row).

Back to Listing

Disclaimer

All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.